Biomarin Pharmaceutical reported $4.5B in Equity Capital and Reserves for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 434.85M 9.95M
Acorda Therapeutics ACOR:US $ 87.91M 39.64M
Agios Pharmaceuticals AGIO:US $ 1124.07M 83.38M
Alnylam Pharmaceuticals ALNY:US $ 176.04M 225.13M
Amgen AMGN:US $ 2419M 1503M
Bayer BAYN:GR € 38019M 582M
Biogen BIIB:US $ 11872.5M 630.2M
Biomarin Pharmaceutical BMRN:US $ 4504.81M 113.49M
Bluebird Bio BLUE:US $ 180.12M 83.14M
Gilead Sciences GILD:US $ 20215M 288M
Insmed INSM:US $ 44.24M 75.64M
Intercept Pharmaceuticals ICPT:US $ -369.83M 1.93M
IONIS PHARMACEUT IONS:US $ 624.73M 84.85M
Moderna Inc MRNA:US 17.98B 910M
Neurocrine Biosciences NBIX:US $ 1423.4M 32.3M
Ptc Therapeutics PTCT:US $ -182.22M 91.64M
Puma Biotechnology PBYI:US $ 19.74M 12.59M
Regeneron Pharmaceuticals REGN:US $ 20687.8M 773.1M
Sangamo Biosciences SGMO:US $ 318.28M 16.24M
Sarepta Therapeutics SRPT:US $ 726.46M 130.43M
Seattle Genetics SGEN:US $ 2932.81M 65.66M
Ultragenyx Pharmaceutical RARE:US $ 678.07M 118.35M
United Therapeutics UTHR:US $ 4318.4M 142.1M
Vertex Pharmaceuticals VRTX:US $ 11933.5M 1026.5M
YTE INCY:US $ 4085.06M 221.99M